TWiV 856: COVID-19 clinical update #98 with Dr. Daniel Griffin
This Week in Virology
00:00
Covid 19 Related Progression to Hospitalization or Death From Any Cause
The article early remdesevere to prevent progression to severe covid 19 in out patients, published in the new england journal of medicine. And this was the result of a randomized, double blind, posipo control trial involving non hospitalized patients with covid 19 who had symptom onset within the previous seven days. The patients were randomly assigned to either receive this three day intervenous remdeciver or placibo. By day 28, 562 patients were randomized, two, 79 Remdesevere, two, 83 in the placibo group. No difference as far as adverse events.
Transcript
Play full episode
